The growth of this market is mainly attributed to the shift toward computerized registries from paper-based registries, due to their advantages, is a key driver of market growth. The emergence of the COVID-19 pandemic and the increase in the number of COVID-19 patients globally is also expected to support the demand for patient registry software.
The report Patient Registry Software Market is projected to
reach USD 2.4 billion by 2025 from USD 1.2 billion in 2020, at a CAGR of 14.4%
from 2020 to 2025.
Ask
for PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144694594
Market
Segmentation:-
Based on the type of
registry, the patient registry software market is segmented into product
registries, health service registries, and disease registries. The disease
registries segment accounted for the largest share of 67.2% of the patient
registry software market in 2019.
Based on the
deployment model, the Patient Registry Software Industry is segmented into
on-premise model and cloud-based model. In 2019, on-premise models held 82.6%
of the global patient registry software market. The large share of this segment
can be attributed to the enhanced control and safety of patient data, and the
large number of COVID-19 patients across the globe, which has driven the demand
for registries.
Based on
functionality, the population health management (PHM) segment accounted for the
largest market share of 28.9% in 2019. The large share of this segment can be
primarily attributed to the implementation of favorable regulations, such as
the ACA in the US.
Based on the end
user, the Patient Registry Software Industry is segmented into private payers;
hospitals & medical practices; research centers; pharmaceutical,
biotechnology, & medical device companies; and government organizations
& TPAs. In 2019, the government organizations & TPAs segment accounted
for the largest share of 33.9% of the global patient registry software market.
Recent
Developments
- In
June 2020, ArborMetrix Inc. (US) entered into a partnership with The
Society of Interventional Radiology (SIR) (US) . This partnership aims to
provide the IR Quality Registry to improve patient care by integrating
analytics.
- In
April 2020, IQVIA Holdings Inc. (US), announced the launch COVID-19
registry platform and technology-powered trial matching solution
- In
March 2020, OpenText Corporation (Canada) acquired XMedius (US) To
strengthen OpenText’s leadership in the areas of secure information
exchange, unified communications, and digital fax.
- In
March 2020, ImageTrend Inc. (US) entered into a partnership with American
Heart Association (US) , in this partnership ImageTrend’s Clinical and
Research team will analyze pre-hospital data related to heart attacks and
strokes in patients during the COVID-19 pandemic.
- InJanuary
2020, M2S . (US) announced the launch Vascular Medicine Consult Registry.
Regional
Analysis: -
The patient registry
software market is segmented into five major regions, namely, North America,
Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In
2019, North America accounted for the largest share of 48.9% of the global
patient registry software market.
Request
for Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=144694594
Top
key Players: -
Some of the prominent
players in this market are Phytel, Inc. (US), IQVIA Holdings, Inc. (US),
OpenText Corporation (Canada), ImageTrend, Inc. (US), FIGmd, Inc. (US), Syneos
Health Inc. (US) and McKesson Corporation (US).
No comments:
Post a Comment